Portfolio company
Innate Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Granite Bio
This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.
Edesa Biotech
This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.
Arxx Therapeutics
This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.
Inotrem
This biopharmaceutical company develops immunotherapies targeting the TREM-1 pathway for patients suffering from acute inflammatory syndromes such as septic shock.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
FF Pharmaceuticals
This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.
